- Home
- XRAY vs RNA Comparison
XRAY vs RNA Comparison
Compare XRAY & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRAY
- RNA
- Stock Information
- Founded
- XRAY 1899
- RNA 2012
- Country
- XRAY United States
- RNA United States
- Employees
- XRAY N/A
- RNA N/A
- Industry
- XRAY Medical/Dental Instruments
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- XRAY Health Care
- RNA Health Care
- Exchange
- XRAY Nasdaq
- RNA Nasdaq
- Market Cap
- XRAY 3.1B
- RNA 3.7B
- IPO Year
- XRAY 1987
- RNA 2020
- Fundamental
- Price
- XRAY $14.93
- RNA $31.60
- Analyst Decision
- XRAY Hold
- RNA Strong Buy
- Analyst Count
- XRAY 13
- RNA 12
- Target Price
- XRAY $23.36
- RNA $68.25
- AVG Volume (30 Days)
- XRAY 3.4M
- RNA 1.3M
- Earning Date
- XRAY 05-01-2025
- RNA 05-08-2025
- Dividend Yield
- XRAY 4.29%
- RNA N/A
- EPS Growth
- XRAY N/A
- RNA N/A
- EPS
- XRAY N/A
- RNA N/A
- Revenue
- XRAY $3,793,000,000.00
- RNA $10,897,000.00
- Revenue This Year
- XRAY N/A
- RNA N/A
- Revenue Next Year
- XRAY $2.56
- RNA $230.08
- P/E Ratio
- XRAY N/A
- RNA N/A
- Revenue Growth
- XRAY N/A
- RNA 13.98
- 52 Week Low
- XRAY $14.78
- RNA $21.56
- 52 Week High
- XRAY $33.22
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- XRAY 30.25
- RNA 50.31
- Support Level
- XRAY $15.34
- RNA $30.12
- Resistance Level
- XRAY $16.02
- RNA $33.13
- Average True Range (ATR)
- XRAY 0.49
- RNA 2.14
- MACD
- XRAY 0.06
- RNA 0.14
- Stochastic Oscillator
- XRAY 11.36
- RNA 35.92
About XRAY DENTSPLY SIRONA Inc.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.